Clinical Trial Update: AvertD Post-Approval Study

View source ↗

Summary

An update indicating that a post-approval study for AvertD in opioid use disorder is currently in recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• AvertD

Snippet

Sponsor: Prescient Medicine Holdings, Inc. | Conditions: Opioid Use Disorder | Status: RECRUITING